Document is current
Any future updates will be listed below
-
Authors
Sisodia, V.
Swinnen, B. E. K. S.
Dijk, J. M.
Verwijk, E.
van Rooijen, G.
Lemstra, A. W.
Schuurman, P. R.
de Bie, R. M. A. http://orcid.org/0000-0001-5267-0784
-
Funding
Funding for this research was provided by:
Stichting Bavalo
- License Information
-
More Information
Article History
Received: 13 October 2022
Accepted: 19 February 2023
First Online: 21 April 2023
Declarations
:
: The study will be conducted according to the principles of the Declaration of Helsinki (version of 2013) and in accordance with the Medical Research Involving Human Subjects Act (WMO) and other guidelines, regulations and Acts. Ethics approval was provided by the medical ethics committee (METC) of Amsterdam UMC, the Netherlands. Study monitoring will be performed in accordance with the ICH GCP guidelines. Written informed consent will be obtained from study participants.
: Not applicable.
: JD received an unconditional supplementary grant from Medtronic for a randomized controlled trial comparing treatment with deep brain stimulation and continuous intrajejunal levodopa in advanced Parkinson’s disease (INVEST study). RdB received funding for research, paid to the institution, from Medtronic. RS is consultant for Boston Scientific, Medtronic and Elekta on educational matters. The other authors have no competing interests.
